Smolders EJ - Search Results

1

The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview.

Giraud EL, Ferrier KRM, Lankheet NAG, Desar IME, Steeghs N, Beukema RJ, van Erp NP, Smolders EJ. Giraud EL, et al. Among authors: smolders ej. Lancet Oncol. 2022 Sep;23(9):e406-e415. doi: 10.1016/S1470-2045(22)00221-2. Lancet Oncol. 2022. PMID: 36055309 Review.

2

QT prolongation with anticancer drugs: a multimodal issue - Authors' reply.

Giraud EL, van Erp NP, Smolders EJ. Giraud EL, et al. Among authors: smolders ej. Lancet Oncol. 2022 Dec;23(12):e523. doi: 10.1016/S1470-2045(22)00695-7. Lancet Oncol. 2022. PMID: 36455572 No abstract available.

3

Cardiovascular Risk Management and Hepatitis C: Combining Drugs.

Smolders EJ, Ter Horst PJG, Wolters S, Burger DM. Smolders EJ, et al. Clin Pharmacokinet. 2019 May;58(5):565-592. doi: 10.1007/s40262-018-0710-1. Clin Pharmacokinet. 2019. PMID: 30259390 Free PMC article. Review.

4

Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update.

Smolders EJ, Jansen AME, Ter Horst PGJ, Rockstroh J, Back DJ, Burger DM. Smolders EJ, et al. Clin Pharmacokinet. 2019 Oct;58(10):1237-1263. doi: 10.1007/s40262-019-00774-0. Clin Pharmacokinet. 2019. PMID: 31114957 Free PMC article. Review.

5

An update on extravasation: basic knowledge for clinical pharmacists.

Smolders EJ, Benoist GE, Smit CCH, Ter Horst P. Smolders EJ, et al. Eur J Hosp Pharm. 2020 Apr 27;28(3):165-7. doi: 10.1136/ejhpharm-2019-002152. Online ahead of print. Eur J Hosp Pharm. 2020. PMID: 32341081 Free PMC article.

6

SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection.

Smolders EJ, Te Brake LH, Burger DM. Smolders EJ, et al. Antivir Ther. 2020;25(7):345-347. doi: 10.3851/IMP3365. Antivir Ther. 2020. PMID: 32589165

7

Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.

Marra F, Smolders EJ, El-Sherif O, Boyle A, Davidson K, Sommerville AJ, Marzolini C, Siccardi M, Burger D, Gibbons S, Khoo S, Back D. Marra F, et al. Among authors: smolders ej. Drugs R D. 2021 Mar;21(1):9-27. doi: 10.1007/s40268-020-00333-0. Epub 2020 Dec 17. Drugs R D. 2021. PMID: 33336316 Free PMC article. Review.

8

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment.

Smolders EJ, de Kanter CT, van Hoek B, Arends JE, Drenth JP, Burger DM. Smolders EJ, et al. Drug Saf. 2016 Jul;39(7):589-611. doi: 10.1007/s40264-016-0420-2. Drug Saf. 2016. PMID: 27098247 Free PMC article. Review.

9

Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications.

Smolders EJ, de Kanter CT, de Knegt RJ, van der Valk M, Drenth JP, Burger DM. Smolders EJ, et al. Clin Pharmacokinet. 2016 Dec;55(12):1471-1494. doi: 10.1007/s40262-016-0407-2. Clin Pharmacokinet. 2016. PMID: 27317413 Free PMC article. Review.

10

A call for a consortium for optimal management of drug-drug interactions in patient care.

Burger DM, Smolders EJ, Schapiro J, Drenth J, Back DJ. Burger DM, et al. Among authors: smolders ej. Clin Pharmacol Ther. 2017 Sep;102(3):391-394. doi: 10.1002/cpt.648. Epub 2017 Mar 17. Clin Pharmacol Ther. 2017. PMID: 28160270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters